-100
NPS Score
VS
Intercept Pharmaceuticals
- EMPLOYEE
PARTICIPANTS - 8
- TOTAL
RATINGS
Novavax
- EMPLOYEE
PARTICIPANTS - 14
- TOTAL
RATINGS
Intercept Pharmaceuticals vs Novavax
Compare Intercept Pharmaceuticals versus Novavax for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 8 employees and customers of Intercept Pharmaceuticals and 14 employees and customers of Novavax.
Intercept Pharmaceuticals
Intercept Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Intercept Pharmaceuticals. Their current market cap is $801.62M.
Novavax
Novavax's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Novavax. Their current market cap is $13.39B.
4/5
Product Quality
3.4/5
2.5/5
Pricing
2.7/5
2.5/5
Customer Service
4.2/5
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |
0
NPS Score
| 25% | Promoters |
|---|---|
| 50% | Passive |
| 25% | Detractors |
Net Promoter Score
Winner by 100
See how Intercept Pharmaceuticals compares to its competitors
See how Novavax compares to its competitors
Working at Intercept Pharmaceuticals vs Working at Novavax
85 / 100
CEO Rating
Winner by 33%
52 / 100
CEO Rating
Intercept Pharmaceuticals
Intercept Pharmaceuticals doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Novavax
Employees at Novavax rate their CEO, Stanley Erck, 52/100. This score is 33% lower than the scores of Intercept Pharmaceuticals' CEO, Mark Pruzanski.